Global Diabetes Therapeutics and Diagnostics Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

January 2019 | 148 pages | ID: GD9C25E6CD2EN
GlobalInfoResearch

Abstracts

This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.

Scope of the Report:

This report focuses on the Diabetes Therapeutics and Diagnostics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Diabetes Therapeutics and Diagnostics is expected to grow at a CAGR of roughly 4.4% over the next five years, will reach 165700 million US$ in 2023, from 128000 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• 77 Elektronika Kft.
• A. Menarini Diagnostics S.R.L
• Abbott Laboratories
• Agamatrix Inc.
• Animas Corp.
• Ascensia
• Becton Dickinson
• Debiotech S.A.
• Eli Lilly And Co.
• Glaxo Smithkline
• Inlight Solutions Inc.
• Johnson & Johnson
• Lifescan Inc.
• Medtronic
• Merck & Co.
• Merck KGAA
• Nipro Corp.
• Novartis Pharma Ag
• Novo Nordisk A/S
• Owen Mumford Ltd.
• Palco Labs Inc.
• Roche
• Sanofi
• Takeda Pharmaceutical Co. Ltd.
• Terumo Corp.

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Insulin
• Insulin Delivery
• Oral Hypoglycemic Drugs
• Diagnosis And Monitoring
• Others

Market Segment by Applications, can be divided into

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Others

There are 15 Chapters to deeply display the global Diabetes Therapeutics and Diagnostics market.
Chapter 1, to describe Diabetes Therapeutics and Diagnostics Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Diabetes Therapeutics and Diagnostics, with sales, revenue, and price of Diabetes Therapeutics and Diagnostics, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Diabetes Therapeutics and Diagnostics, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Diabetes Therapeutics and Diagnostics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Diabetes Therapeutics and Diagnostics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Diabetes Therapeutics and Diagnostics Introduction
1.2 Market Analysis by Type
  1.2.1 Insulin
  1.2.2 Insulin Delivery
  1.2.3 Oral Hypoglycemic Drugs
  1.2.4 Diagnosis And Monitoring
  1.2.5 Others
1.3 Market Analysis by Applications
  1.3.1 Type 1 Diabetes
  1.3.2 Type 2 Diabetes
  1.3.3 Gestational Diabetes
  1.3.4 Others
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 77 Elektronika Kft.
  2.1.1 Business Overview
  2.1.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 A. Menarini Diagnostics S.R.L
  2.2.1 Business Overview
  2.2.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Abbott Laboratories
  2.3.1 Business Overview
  2.3.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Abbott Laboratories Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Agamatrix Inc.
  2.4.1 Business Overview
  2.4.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Animas Corp.
  2.5.1 Business Overview
  2.5.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Animas Corp. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Ascensia
  2.6.1 Business Overview
  2.6.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Ascensia Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Becton Dickinson
  2.7.1 Business Overview
  2.7.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Becton Dickinson Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Debiotech S.A.
  2.8.1 Business Overview
  2.8.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Debiotech S.A. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Eli Lilly And Co.
  2.9.1 Business Overview
  2.9.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Glaxo Smithkline
  2.10.1 Business Overview
  2.10.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Inlight Solutions Inc.
  2.11.1 Business Overview
  2.11.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.11.2.1 Product A
    2.11.2.2 Product B
  2.11.3 Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Johnson & Johnson
  2.12.1 Business Overview
  2.12.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.12.2.1 Product A
    2.12.2.2 Product B
  2.12.3 Johnson & Johnson Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Lifescan Inc.
  2.13.1 Business Overview
  2.13.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.13.2.1 Product A
    2.13.2.2 Product B
  2.13.3 Lifescan Inc. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Medtronic
  2.14.1 Business Overview
  2.14.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.14.2.1 Product A
    2.14.2.2 Product B
  2.14.3 Medtronic Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Merck & Co.
  2.15.1 Business Overview
  2.15.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.15.2.1 Product A
    2.15.2.2 Product B
  2.15.3 Merck & Co. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Merck KGAA
  2.16.1 Business Overview
  2.16.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.16.2.1 Product A
    2.16.2.2 Product B
  2.16.3 Merck KGAA Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Nipro Corp.
  2.17.1 Business Overview
  2.17.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.17.2.1 Product A
    2.17.2.2 Product B
  2.17.3 Nipro Corp. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Novartis Pharma Ag
  2.18.1 Business Overview
  2.18.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.18.2.1 Product A
    2.18.2.2 Product B
  2.18.3 Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Novo Nordisk A/S
  2.19.1 Business Overview
  2.19.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.19.2.1 Product A
    2.19.2.2 Product B
  2.19.3 Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Owen Mumford Ltd.
  2.20.1 Business Overview
  2.20.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.20.2.1 Product A
    2.20.2.2 Product B
  2.20.3 Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Palco Labs Inc.
  2.21.1 Business Overview
  2.2.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.21.2.1 Product A
    2.21.2.2 Product B
  2.21.3 Palco Labs Inc. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 Roche
  2.22.1 Business Overview
  2.22.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.22.2.1 Product A
    2.22.2.2 Product B
  2.22.3 Roche Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.23 Sanofi
  2.23.1 Business Overview
  2.23.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.23.2.1 Product A
    2.23.2.2 Product B
  2.23.3 Sanofi Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.24 Takeda Pharmaceutical Co. Ltd.
  2.24.1 Business Overview
  2.24.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.24.2.1 Product A
    2.24.2.2 Product B
  2.24.3 Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.25 Terumo Corp.
  2.25.1 Business Overview
  2.25.2 Diabetes Therapeutics and Diagnostics Type and Applications
    2.25.2.1 Product A
    2.25.2.2 Product B
  2.25.3 Terumo Corp. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL DIABETES THERAPEUTICS AND DIAGNOSTICS SALES, REVENUE, MARKET SHARE AND COMPETITION BY MANUFACTURER (2016-2017)

3.1 Global Diabetes Therapeutics and Diagnostics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Diabetes Therapeutics and Diagnostics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
  3.3.1 Top 3 Diabetes Therapeutics and Diagnostics Manufacturer Market Share in 2017
  3.3.2 Top 6 Diabetes Therapeutics and Diagnostics Manufacturer Market Share in 2017
3.4 Market Competition Trend

4 GLOBAL DIABETES THERAPEUTICS AND DIAGNOSTICS MARKET ANALYSIS BY REGIONS

4.1 Global Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Regions
  4.1.1 Global Diabetes Therapeutics and Diagnostics Sales and Market Share by Regions (2013-2018)
  4.1.2 Global Diabetes Therapeutics and Diagnostics Revenue and Market Share by Regions (2013-2018)
4.2 North America Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
4.3 Europe Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
4.5 South America Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)

5 NORTH AMERICA DIABETES THERAPEUTICS AND DIAGNOSTICS BY COUNTRIES

5.1 North America Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries
  5.1.1 North America Diabetes Therapeutics and Diagnostics Sales and Market Share by Countries (2013-2018)
  5.1.2 North America Diabetes Therapeutics and Diagnostics Revenue and Market Share by Countries (2013-2018)
5.2 United States Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
5.3 Canada Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
5.4 Mexico Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)

6 EUROPE DIABETES THERAPEUTICS AND DIAGNOSTICS BY COUNTRIES

6.1 Europe Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries
  6.1.1 Europe Diabetes Therapeutics and Diagnostics Sales and Market Share by Countries (2013-2018)
  6.1.2 Europe Diabetes Therapeutics and Diagnostics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
6.3 UK Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
6.4 France Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
6.5 Russia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
6.6 Italy Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)

7 ASIA-PACIFIC DIABETES THERAPEUTICS AND DIAGNOSTICS BY COUNTRIES

7.1 Asia-Pacific Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Diabetes Therapeutics and Diagnostics Sales and Market Share by Countries (2013-2018)
  7.1.2 Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue and Market Share by Countries (2013-2018)
7.2 China Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
7.3 Japan Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
7.4 Korea Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
7.5 India Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)

8 SOUTH AMERICA DIABETES THERAPEUTICS AND DIAGNOSTICS BY COUNTRIES

8.1 South America Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries
  8.1.1 South America Diabetes Therapeutics and Diagnostics Sales and Market Share by Countries (2013-2018)
  8.1.2 South America Diabetes Therapeutics and Diagnostics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
8.3 Argentina Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
8.4 Colombia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA DIABETES THERAPEUTICS AND DIAGNOSTICS BY COUNTRIES

9.1 Middle East and Africa Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Diabetes Therapeutics and Diagnostics Sales and Market Share by Countries (2013-2018)
  9.1.2 Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
9.3 UAE Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
9.4 Egypt Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
9.5 Nigeria Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
9.6 South Africa Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)

10 GLOBAL DIABETES THERAPEUTICS AND DIAGNOSTICS MARKET SEGMENT BY TYPE

10.1 Global Diabetes Therapeutics and Diagnostics Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Diabetes Therapeutics and Diagnostics Sales and Market Share by Type (2013-2018)
  10.1.2 Global Diabetes Therapeutics and Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Insulin Sales Growth and Price
  10.2.1 Global Insulin Sales Growth (2013-2018)
  10.2.2 Global Insulin Price (2013-2018)
10.3 Insulin Delivery Sales Growth and Price
  10.3.1 Global Insulin Delivery Sales Growth (2013-2018)
  10.3.2 Global Insulin Delivery Price (2013-2018)
10.4 Oral Hypoglycemic Drugs Sales Growth and Price
  10.4.1 Global Oral Hypoglycemic Drugs Sales Growth (2013-2018)
  10.4.2 Global Oral Hypoglycemic Drugs Price (2013-2018)
10.5 Diagnosis And Monitoring Sales Growth and Price
  10.5.1 Global Diagnosis And Monitoring Sales Growth (2013-2018)
  10.5.2 Global Diagnosis And Monitoring Price (2013-2018)
10.6 Others Sales Growth and Price
  10.6.1 Global Others Sales Growth (2013-2018)
  10.6.2 Global Others Price (2013-2018)

11 GLOBAL DIABETES THERAPEUTICS AND DIAGNOSTICS MARKET SEGMENT BY APPLICATION

11.1 Global Diabetes Therapeutics and Diagnostics Sales Market Share by Application (2013-2018)
11.2 Type 1 Diabetes Sales Growth (2013-2018)
11.3 Type 2 Diabetes Sales Growth (2013-2018)
11.4 Gestational Diabetes Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)

12 DIABETES THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST (2018-2023)

12.1 Global Diabetes Therapeutics and Diagnostics Sales, Revenue and Growth Rate (2018-2023)
12.2 Diabetes Therapeutics and Diagnostics Market Forecast by Regions (2018-2023)
  12.2.1 North America Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023)
  12.2.2 Europe Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023)
  12.2.4 South America Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023)
12.3 Diabetes Therapeutics and Diagnostics Market Forecast by Type (2018-2023)
  12.3.1 Global Diabetes Therapeutics and Diagnostics Sales Forecast by Type (2018-2023)
  12.3.2 Global Diabetes Therapeutics and Diagnostics Market Share Forecast by Type (2018-2023)
12.4 Diabetes Therapeutics and Diagnostics Market Forecast by Application (2018-2023)
  12.4.1 Global Diabetes Therapeutics and Diagnostics Sales Forecast by Application (2018-2023)
  12.4.2 Global Diabetes Therapeutics and Diagnostics Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Diabetes Therapeutics and Diagnostics Picture
Table Product Specifications of Diabetes Therapeutics and Diagnostics
Figure Global Sales Market Share of Diabetes Therapeutics and Diagnostics by Types in 2017
Table Diabetes Therapeutics and Diagnostics Types for Major Manufacturers
Figure Insulin Picture
Figure Insulin Delivery Picture
Figure Oral Hypoglycemic Drugs Picture
Figure Diagnosis And Monitoring Picture
Figure Others Picture
Figure Diabetes Therapeutics and Diagnostics Sales Market Share by Applications in 2017
Figure Type 1 Diabetes Picture
Figure Type 2 Diabetes Picture
Figure Gestational Diabetes Picture
Figure Others Picture
Figure United States Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure France Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure China Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure India Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Diabetes Therapeutics and Diagnostics Revenue (Value) and Growth Rate (2013-2023)
Table 77 Elektronika Kft. Basic Information, Manufacturing Base and Competitors
Table 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Type and Applications
Table 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table A. Menarini Diagnostics S.R.L Basic Information, Manufacturing Base and Competitors
Table A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Type and Applications
Table A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table Abbott Laboratories Diabetes Therapeutics and Diagnostics Type and Applications
Table Abbott Laboratories Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Agamatrix Inc. Basic Information, Manufacturing Base and Competitors
Table Agamatrix Inc. Diabetes Therapeutics and Diagnostics Type and Applications
Table Agamatrix Inc. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Animas Corp. Basic Information, Manufacturing Base and Competitors
Table Animas Corp. Diabetes Therapeutics and Diagnostics Type and Applications
Table Animas Corp. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ascensia Basic Information, Manufacturing Base and Competitors
Table Ascensia Diabetes Therapeutics and Diagnostics Type and Applications
Table Ascensia Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Becton Dickinson Basic Information, Manufacturing Base and Competitors
Table Becton Dickinson Diabetes Therapeutics and Diagnostics Type and Applications
Table Becton Dickinson Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Debiotech S.A. Basic Information, Manufacturing Base and Competitors
Table Debiotech S.A. Diabetes Therapeutics and Diagnostics Type and Applications
Table Debiotech S.A. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly And Co. Basic Information, Manufacturing Base and Competitors
Table Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Type and Applications
Table Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Glaxo Smithkline Basic Information, Manufacturing Base and Competitors
Table Glaxo Smithkline Diabetes Therapeutics and Diagnostics Type and Applications
Table Glaxo Smithkline Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Inlight Solutions Inc. Basic Information, Manufacturing Base and Competitors
Table Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Type and Applications
Table Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Diabetes Therapeutics and Diagnostics Type and Applications
Table Johnson & Johnson Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Lifescan Inc. Basic Information, Manufacturing Base and Competitors
Table Lifescan Inc. Diabetes Therapeutics and Diagnostics Type and Applications
Table Lifescan Inc. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Medtronic Basic Information, Manufacturing Base and Competitors
Table Medtronic Diabetes Therapeutics and Diagnostics Type and Applications
Table Medtronic Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co. Basic Information, Manufacturing Base and Competitors
Table Merck & Co. Diabetes Therapeutics and Diagnostics Type and Applications
Table Merck & Co. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck KGAA Basic Information, Manufacturing Base and Competitors
Table Merck KGAA Diabetes Therapeutics and Diagnostics Type and Applications
Table Merck KGAA Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Nipro Corp. Basic Information, Manufacturing Base and Competitors
Table Nipro Corp. Diabetes Therapeutics and Diagnostics Type and Applications
Table Nipro Corp. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Pharma Ag Basic Information, Manufacturing Base and Competitors
Table Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Type and Applications
Table Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk A/S Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Type and Applications
Table Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Owen Mumford Ltd. Basic Information, Manufacturing Base and Competitors
Table Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Type and Applications
Table Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Palco Labs Inc. Basic Information, Manufacturing Base and Competitors
Table Palco Labs Inc. Diabetes Therapeutics and Diagnostics Type and Applications
Table Palco Labs Inc. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Diabetes Therapeutics and Diagnostics Type and Applications
Table Roche Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Diabetes Therapeutics and Diagnostics Type and Applications
Table Sanofi Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Takeda Pharmaceutical Co. Ltd. Basic Information, Manufacturing Base and Competitors
Table Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Type and Applications
Table Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Terumo Corp. Basic Information, Manufacturing Base and Competitors
Table Terumo Corp. Diabetes Therapeutics and Diagnostics Type and Applications
Table Terumo Corp. Diabetes Therapeutics and Diagnostics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Diabetes Therapeutics and Diagnostics Sales by Manufacturer (2016-2017)
Figure Global Diabetes Therapeutics and Diagnostics Sales Market Share by Manufacturer in 2016
Figure Global Diabetes Therapeutics and Diagnostics Sales Market Share by Manufacturer in 2017
Table Global Diabetes Therapeutics and Diagnostics Revenue by Manufacturer (2016-2017)
Figure Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Manufacturer in 2016
Figure Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Manufacturer in 2017
Figure Top 3 Diabetes Therapeutics and Diagnostics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Diabetes Therapeutics and Diagnostics Manufacturer (Revenue) Market Share in 2017
Figure Global Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Global Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Sales by Regions (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Sales Market Share by Regions (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Revenue by Regions (2013-2018)
Figure Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Regions in 2013
Figure Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Regions in 2017
Figure North America Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Europe Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure South America Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure North America Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
Table North America Diabetes Therapeutics and Diagnostics Sales by Countries (2013-2018)
Table North America Diabetes Therapeutics and Diagnostics Sales Market Share by Countries (2013-2018)
Figure North America Diabetes Therapeutics and Diagnostics Sales Market Share by Countries in 2013
Figure North America Diabetes Therapeutics and Diagnostics Sales Market Share by Countries in 2017
Table North America Diabetes Therapeutics and Diagnostics Revenue by Countries (2013-2018)
Table North America Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries (2013-2018)
Figure North America Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries in 2013
Figure North America Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries in 2017
Figure United States Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Canada Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Mexico Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Europe Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
Table Europe Diabetes Therapeutics and Diagnostics Sales by Countries (2013-2018)
Table Europe Diabetes Therapeutics and Diagnostics Sales Market Share by Countries (2013-2018)
Table Europe Diabetes Therapeutics and Diagnostics Revenue by Countries (2013-2018)
Figure Europe Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries in 2016
Figure Europe Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries in 2017
Figure Germany Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure UK Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure France Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Russia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Italy Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Diabetes Therapeutics and Diagnostics Sales by Countries (2013-2018)
Table Asia-Pacific Diabetes Therapeutics and Diagnostics Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Diabetes Therapeutics and Diagnostics Sales Market Share by Countries 2017
Table Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue by Countries (2013-2018)
Figure Asia-Pacific Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries 2017
Figure China Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Japan Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Korea Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure India Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Southeast Asia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure South America Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
Table South America Diabetes Therapeutics and Diagnostics Sales by Countries (2013-2018)
Table South America Diabetes Therapeutics and Diagnostics Sales Market Share by Countries (2013-2018)
Figure South America Diabetes Therapeutics and Diagnostics Sales Market Share by Countries in 2017
Table South America Diabetes Therapeutics and Diagnostics Revenue by Countries (2013-2018)
Table South America Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries (2013-2018)
Figure South America Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries in 2017
Figure Brazil Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Argentina Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Colombia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Diabetes Therapeutics and Diagnostics Sales by Countries (2013-2018)
Table Middle East and Africa Diabetes Therapeutics and Diagnostics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Diabetes Therapeutics and Diagnostics Sales Market Share by Countries in 2017
Table Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue by Countries (2013-2018)
Table Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries in 2013
Figure Middle East and Africa Diabetes Therapeutics and Diagnostics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure UAE Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Egypt Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure Nigeria Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Figure South Africa Diabetes Therapeutics and Diagnostics Sales and Growth Rate (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Sales by Type (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Sales Share by Type (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Revenue by Type (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Revenue Share by Type (2013-2018)
Figure Global Insulin Sales Growth (2013-2018)
Figure Global Insulin Price (2013-2018)
Figure Global Insulin Delivery Sales Growth (2013-2018)
Figure Global Insulin Delivery Price (2013-2018)
Figure Global Oral Hypoglycemic Drugs Sales Growth (2013-2018)
Figure Global Oral Hypoglycemic Drugs Price (2013-2018)
Figure Global Diagnosis And Monitoring Sales Growth (2013-2018)
Figure Global Diagnosis And Monitoring Price (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Others Price (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Sales by Application (2013-2018)
Table Global Diabetes Therapeutics and Diagnostics Sales Share by Application (2013-2018)
Figure Global Type 2 Diabetes Sales Growth (2013-2018)
Figure Global Gestational Diabetes Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Diabetes Therapeutics and Diagnostics Sales, Revenue and Growth Rate (2018-2023)
Table Global Diabetes Therapeutics and Diagnostics Sales Forecast by Regions (2018-2023)
Table Global Diabetes Therapeutics and Diagnostics Market Share Forecast by Regions (2018-2023)
Figure North America Sales Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023)
Figure Europe Sales Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023)
Figure Asia-Pacific Sales Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023)
Figure South America Sales Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023)
Figure Middle East and Africa Sales Diabetes Therapeutics and Diagnostics Market Forecast (2018-2023)
Table Global Diabetes Therapeutics and Diagnostics Sales Forecast by Type (2018-2023)
Table Global Diabetes Therapeutics and Diagnostics Market Share Forecast by Type (2018-2023)
Table Global Diabetes Therapeutics and Diagnostics Sales Forecast by Application (2018-2023)
Table Global Diabetes Therapeutics and Diagnostics Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List